[go: up one dir, main page]

ZA200004819B - Mutant recombinant allergens. - Google Patents

Mutant recombinant allergens.

Info

Publication number
ZA200004819B
ZA200004819B ZA200004819A ZA200004819A ZA200004819B ZA 200004819 B ZA200004819 B ZA 200004819B ZA 200004819 A ZA200004819 A ZA 200004819A ZA 200004819 A ZA200004819 A ZA 200004819A ZA 200004819 B ZA200004819 B ZA 200004819B
Authority
ZA
South Africa
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
ZA200004819A
Other languages
English (en)
Inventor
Hans Henrik Ipsen
Michael Dho Spangfort
Jorgen Nedergaard Larsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200004819(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of ZA200004819B publication Critical patent/ZA200004819B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200004819A 1998-03-16 2000-09-12 Mutant recombinant allergens. ZA200004819B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16

Publications (1)

Publication Number Publication Date
ZA200004819B true ZA200004819B (en) 2001-05-30

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200004819A ZA200004819B (en) 1998-03-16 2000-09-12 Mutant recombinant allergens.

Country Status (19)

Country Link
US (1) US20040091500A1 (xx)
EP (1) EP1062341B1 (xx)
JP (1) JP2002506648A (xx)
KR (1) KR20010041918A (xx)
CN (1) CN1332029C (xx)
AT (1) ATE408690T1 (xx)
AU (1) AU749749B2 (xx)
CA (1) CA2323687C (xx)
DE (1) DE69939584D1 (xx)
DK (1) DK1062341T3 (xx)
ES (1) ES2313776T3 (xx)
HU (1) HUP0101464A3 (xx)
IL (2) IL138339A0 (xx)
NO (1) NO328354B1 (xx)
NZ (1) NZ506665A (xx)
PL (1) PL194804B1 (xx)
PT (1) PT1062341E (xx)
WO (1) WO1999047680A1 (xx)
ZA (1) ZA200004819B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001254622A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Laccase mutants
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
CZ20031653A3 (en) * 2000-11-16 2004-03-17 Alk-Abelló A/S Mutant allergens
DE60032250T2 (de) * 2000-12-28 2007-03-15 Biomay Produktions- Und Handels-Aktiengesellschaft Behandlung von Allergien
DK1499349T3 (da) * 2001-03-02 2010-04-06 Univ Rockefeller Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet
CA2462651A1 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
ES2333951T5 (es) * 2002-02-27 2017-11-16 Merck Patent Gmbh Método para producir alergenos principales rBet v 1 hipoalergénicos de abedul
WO2003096869A2 (en) * 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
US7384635B2 (en) * 2002-11-01 2008-06-10 Alk-Abello A/S Protein variants of naturally occurring allergens
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
KR101136573B1 (ko) 2003-02-28 2012-04-23 알크-아벨로 에이/에스 당류 매트릭스를 갖는 제형
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
AU2004298719B8 (en) 2003-12-19 2011-04-07 Alk-Abello A/S Cryogranulation and storage method for active pharmaceutical agents
EP2324850A1 (en) 2005-10-04 2011-05-25 Alk-Abelló A/S Solid vaccine formulation
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
AU2007241557A1 (en) * 2006-04-20 2007-11-01 National University Of Singapore Recombinant lactobacillus and use of the same
EP2129389B1 (en) * 2007-02-15 2014-10-08 MannKind Corporation A method for enhancing t cell response
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
ES2606550T3 (es) 2009-06-19 2017-03-24 Alk-Abelló S.A. Nueva manera de administrar alérgeno en inmunoterapia específica con alérgenos
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
AU743647B2 (en) * 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
DE69939584D1 (de) 2008-10-30
IL138339A (en) 2009-06-15
CN1332029C (zh) 2007-08-15
WO1999047680A1 (en) 1999-09-23
NO328354B1 (no) 2010-02-01
HUP0101464A3 (en) 2004-10-28
NO20004614D0 (no) 2000-09-15
IL138339A0 (en) 2001-10-31
US20040091500A1 (en) 2004-05-13
AU2714799A (en) 1999-10-11
DK1062341T3 (da) 2008-11-03
PT1062341E (pt) 2008-12-24
PL194804B1 (pl) 2007-07-31
CA2323687C (en) 2008-11-25
ES2313776T3 (es) 2009-03-01
EP1062341B1 (en) 2008-09-17
KR20010041918A (ko) 2001-05-25
CA2323687A1 (en) 1999-09-23
ATE408690T1 (de) 2008-10-15
HK1033591A1 (en) 2001-09-07
NZ506665A (en) 2003-08-29
EP1062341A1 (en) 2000-12-27
JP2002506648A (ja) 2002-03-05
HUP0101464A2 (hu) 2001-08-28
NO20004614L (no) 2000-10-26
CN1293710A (zh) 2001-05-02
AU749749B2 (en) 2002-07-04
PL343029A1 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
ZA200004819B (en) Mutant recombinant allergens.
AU2350502A (en) Novel mutant allergens
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
AP2001002187A0 (en) Piperidines as CCR5 modulators.
AU3227700A (en) Skin sanitizing compositions
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
BG102818A (en) D-manitol and method for its preparation
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
MX9708426A (es) Polipeptido hk2 de variante estable.
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
NO20001421D0 (no) T-cellevaksinasjon for behandling av multippel sklerose
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
BG101787A (en) Aprotinine options having improved properties
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
GB2374871A (en) Peptide fragments of colostrinin and their use
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases